Advanced virus detection technologies interest group (AVDTIG): Efforts on high throughput sequencing (HTS) for virus detection

PDA Journal of Pharmaceutical Science and Technology

Volumn 70, Issue 6, 2016, Pages 591-595

  Khan, Arifa S ^a   Vacante, Dominick A ^b   Cassart, Jean Pol ^c   Ng, Siemon H S ^d   Lambert, Christophe ^c   Charlebois, Robert L ^d   King, Kathryn E ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^c GSK   (Belgium)

^d Sanofi Pasteur   (Canada)

Author keywords

Adventitious viruses; High throughput sequencing; Massively parallel sequencing; New technologies; Next generation sequencing; Virus detection

Indexed keywords

APPLICATION SERVICE PROVIDER; BIOINFORMATICS; CONTROLLED STUDY; GOVERNMENT; HIGH THROUGHPUT SEQUENCING; INFORMATION TECHNOLOGY; NONHUMAN; ORGANIZATION; REVIEW; SCIENTIST; VIRUS DETECTION; BIOLOGY; ISOLATION AND PURIFICATION; PHARMACEUTICS; PUBLIC OPINION; VIRUS;

COMPUTATIONAL BIOLOGY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; PUBLIC OPINION; TECHNOLOGY, PHARMACEUTICAL; VIRUSES;

EID: 85015914002     PISSN: 10797440     EISSN: 19482124     Source Type: Journal    
DOI: 10.5731/pdajpst.2016.007161     Document Type: Review

References (11)

1. Khan, A. S.; King, K.E.; Brack, K.; Cassart, J-P.; Chiu, C.; Dehghani, H.; Duncan, P.; Jaing, C.; Kolman, J.; Munroe, D.; Palermo, A.; Plavsic, M.; Sampath, R.; Slezak, T,; Takle, G.; Taliaferro, L.P.; Toso, E., Vacante, D., Willkommen, H. et al. Emerging Methods for Virus Detection, Technical Report No. 71. Parenteral Drug Association, 2015.
2. Quality Guideline Q5A(R1): Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin; International Conference on Harmonisation: 1999, www. ich.org (accessed April 23, 2016).
3. Guidance for Industry: Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications; U.S. Food and Drug Administration, 2010, http://www. fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/UCM202439.pdf (accessed April 23, 2016).
4. Recommendations for the Evaluation of Animal Cell Cultures as Substrates for the Manufacture of Biological Medicinal Products and for the Characterization of Cell Banks: TRS 878, Annex 1. World Health Organization, 2010, http://www. who.int/biologicals/Cell-Substrates-clean-version-18-April.pdf (accessed April 23, 2016).
5. Quality Guideline Q5D: Derivation and Characterisation of Cell Substrates Used for Production of Biotechnological/Biological Products; International Conference on Harmonisation, 1998, http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/09/WC500003280.pdf (accessed April 23, 2016).
6. Khan, A. S. Testing Considerations for Novel Cell Substrates: A Regulatory Perspective. PDA J. Pharm. Sci. Technol. 2010, 64 (5), 426-431.
7. Victoria, J.; Wang, C.; Jones, M. S.; Jaing, C.; McLoughlin, K.; Gardner, S.; Delwart, E. L. Viral Nucleic Acids in Live-Attenuated Vaccines: Detection of Minority Variants and an Adventitious Virus. J. Virol. 2010, 84 (12), 6033-6040.
8. 2012 Meeting Materials: Vaccines and Related Biological Products Advisory Committee; U.S. Food and Drug Administration, 2012, http://www.fda. gov/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/vaccinesandrelatedbiologicalproductsadvisorycommittee/ucm288695.htm, (accessed April 23, 2016).
9. Sheets, R.; Loewer, J.; Raychaudhuri, G.; Petricciani, J. Adventitious Agents, New Technology, and Risk Assessment, 19-20 May 2011, Baltimore, MD. Biologicals 2012, 40 (2), 162-167.
10. Khan, A.; Lubiniecki, A.; King, K. E. PDA/FDA Adventitious Agents and Novel Cell Substrates: Emerging Technologies and New Challenges, November 2-4, 2011, Rockville, MD. PDA J. Pharm. Sci. Technol. 2012, 66 (6), 502-511.
11. Khan, A.; Vacante, D. A. Introduction and Workshop Summary: PDA/FDA Advanced Technologies for Virus Detection in the Evaluation of Biologicals: Applications and Challenges. PDA J. Pharm. Sci. Technol. 2014, 68 (6), 546-547.